China Pharma Holdings (CPHI) Inventory (2010 - 2026)

China Pharma Holdings has reported Inventory for 17 years, with the latest figure at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 45.85% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 45.85% YoY), and the FY2025 full-year result was $2.8 million, down 2.59% from the prior year.
• Inventory for Q1 2026 stood at $1.5 million, down from $2.8 million in the prior quarter.
• The five-year high for Inventory was $3.9 million in Q2 2023, with the low at $1.5 million in Q1 2026.
• Historically, Inventory has averaged $3.1 million across 5 years, with a median of $2.9 million in 2022.
• Annual changes were most pronounced in 2023 — Inventory surged 30.48% — and 2026, when it slumped 45.85%.
• China Pharma Holdings' Inventory stood at $2.9 million in 2022, then advanced by 26.62% to $3.7 million in 2023, then dropped by 23.91% to $2.8 million in 2024, then decreased by 2.59% to $2.8 million in 2025, then slumped by 45.84% to $1.5 million in 2026.
• The last three Inventory figures came in at $1.5 million (Q1 2026), $2.8 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.